1762.TW

Chunghwa Chemical Synthesis & Biotech Co., Ltd. [1762.TW] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

1762.TW Stock Summary

Top 10 Correlated ETFs

1762.TW

Top 10 Correlated Stocks

1762.TW

In the News

1762.TW Financial details

Company Rating
-
Market Cap
3.66B
Income
264.91M
Revenue
2.09B
Book val./share
-
Cash/share
-
Dividend
1.3
Dividend %
2.39%
Employees
243
Optionable
No
Shortable
Yes
Earnings
14 May 2024
P/E
14.81
Forward P/E
-
PEG
-3.42
P/S
1.94
P/B
1.3
P/C
-
P/FCF
-9.02
Quick Ratio
0.24
Current Ratio
2.24
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
3.41
EPS next Y
-
EPS next Q
-
EPS this Y
-43.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
17.76%
Revenue last 5Y
12.52%
Revenue Q/Q
34.34%
EPS Q/Q
280%
-
-
-
-
SMA20
-12.18%
SMA50
-16.99%
SMA100
-25.79%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
9%
ROC
0.09%
Gross Margin
38%
Oper. Margin
17%
Profit Margin
13%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
47.05-102.5
52W High
-71.42%
52W Low
-37.98%
RSI
49.12
Rel Volume
0.39
Avg Volume
299.91K
Volume
116.88K
Perf Week
5.62%
Perf Month
-11.13%
Perf Quarter
-31.33%
Perf Half Y
-31.73%
-
-
-
-
Beta
0.734
-
-
Volatility
0.4%, 2.68%
Prev Close
0%
Price
29.15
Change
0.52%

1762.TW Financial Performance

1762.TW Dividend History

1762.TW Frequently Asked Questions

What is Chunghwa Chemical Synthesis & Biotech Co., Ltd. stock symbol ?

Chunghwa Chemical Synthesis & Biotech Co., Ltd. is a TW stock and trading under the symbol 1762.TW

What is Chunghwa Chemical Synthesis & Biotech Co., Ltd. stock quote today ?

Chunghwa Chemical Synthesis & Biotech Co., Ltd. stock price is $29.15 today.

Is Chunghwa Chemical Synthesis & Biotech Co., Ltd. stock public?

Yes, Chunghwa Chemical Synthesis & Biotech Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
0YXG.L
NVDA
VTI
VFINX
LLY.SW
Top Correlated ETFs
TRIP.L
AMEC.DE
W1TA.DE
RBTX.L
WLDL.L
Top Correlated Stocks
2483.TW
3714.TW
1760.TW
2316.TW
2376.TW
Similar Market Cap
RWR
KHADIM.NS
600573.SS
4916.TW
002009.SZ

Company Profile

Healthcare Biotechnology
  • Volume Average 299.91K
  • Market Capitalization 3.66B
  • Employee 243
  • CEO Mr. Chung-Hsin Huang
  • Headquarters New Taipei City,TW
  • IPO Date 2010-12-20
  • Website https://www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.